Metware Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 450

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 5

Metware General Information

Description

Provider of metabolic analysis and testing services intended to enable life science research and medical health applications. The company offers broad-scope metabolomics and proteomics testing, clinical marker discovery, disease mechanism studies, drug efficacy research, and microbiome-host interaction analysis, providing researchers with precise metabolic data for biomarker identification and disease progression studies.

Contact Information

Website
www.metware.cn
Formerly Known As
Wuhan Maitwell Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building A5, Phase II, Optics Valley Bio-Innovation Park
  • Hongshan District
  • Wuhan, Hubei 430075
  • China
+86 400
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Corporate Office
  • Building A5, Phase II, Optics Valley Bio-Innovation Park
  • Hongshan District
  • Wuhan, Hubei 430075
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Metware Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 02-Apr-2024 Completed Generating Revenue
4. Later Stage VC (Series A) 24-Sep-2021 Completed Generating Revenue
3. Secondary Transaction - Private 04-Jun-2019 Completed Generating Revenue
2. Early Stage VC 21-Sep-2017 $1.83M $1.83M Completed Generating Revenue
1. Early Stage VC 26-May-2017 Completed Generating Revenue
To view Metware’s complete valuation and funding history, request access »

Metware Patents

Metware Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026086969-A1 Chromatography-mass spectrometry automated integration method, system and device for multi-sample project, and medium Pending 23-Oct-2024

Metware Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Metware Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hidea Venture Capital Venture Capital Minority
HSG (Hong Kong) Venture Capital Minority
Billionhome Growth/Expansion Minority
Wuhan Bus Investment Information Growth/Expansion Minority
Wuhan Institute of Biotechnology Government Minority
To view Metware’s complete investors history, request access »

Metware FAQs

  • When was Metware founded?

    Metware was founded in 2015.

  • Where is Metware headquartered?

    Metware is headquartered in Wuhan, China.

  • What is the size of Metware?

    Metware has 450 total employees.

  • What industry is Metware in?

    Metware’s primary industry is Laboratory Services (Healthcare).

  • Is Metware a private or public company?

    Metware is a Private company.

  • What is Metware’s current revenue?

    The current revenue for Metware is .

  • How much funding has Metware raised over time?

    Metware has raised $17.3M.

  • Who are Metware’s investors?

    Hidea Venture Capital, HSG (Hong Kong), Billionhome, Wuhan Bus Investment Information, and Wuhan Institute of Biotechnology have invested in Metware.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process